Who is the Top Investor In Fulcrum Therapeutics Inc (FULC)?
Fulcrum Therapeutics Inc (NASDAQ: FULC) is 67.56% higher on its value in year-to-date trading and has touched a low of $2.25 and a high of $13.70 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Who are the Institutional Holders in Fulcrum Therapeutics Inc (FULC)?
Fulcrum Therapeutics Inc (NASDAQ: FULC) is 52.89% higher on its value in year-to-date trading and has touched a low of $2.25 and a high of $10.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
